Jagan Billakanti
Dr Jagan Billakanti, currently working as a Genomic Medicine Workflow Development Leader, Cytiva ANZ, attained PhD from the University of Canterbury, New Zealand in Chemical & Process Engineering Discipline in 2009. Successfully published >20 peer-reviewed journal articles with 500 citations and presented >20 conferences. Jagan is a dedicated Bioprocess Scientist with over 17 years of combined expertise in the Biopharmaceuticals, Biologics development and Food and beverage industries for new product/technology development, driving innovation to manufacture, and contract manufacturing of API or bulk biological drugs, very familiar with the translational, commercial and manufacturing environment, consistently delivered and supported the life cycle of a wide variety of R&D, Translational and commercial, contract projects within the budget and schedule. My core strengths include workflow designing for end-to-end solutions, discussing product lifecycle, and designing scalable solutions for Cell Therapy, Viral Vectors (AAV, LV, Exosomes), mRNA, saRNA, siRNA, sgRNA, Oligos, Lipid Nano Particles (LNPs), monoclonal antibodies, recombinant proteins and high-value natural proteins from dairy/agriculture/aquaculture sources. Demonstrated excellent communication skills and worked well with various individuals from different technical backgrounds. Jagan is very familiar with 1) GMP and GLP guidelines, 2) ANZ and GB guidelines/methods/standards and 3) FDA, TGA and HACCP guidelines.
https://www.linkedin.com/in/dr-jagan-billakanti-7123984/
Abstracts this author is presenting: